Article
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
International journal of cancer - 1 Sept 2011
Winder Thomas, Ning Yan, Yang Dongyun, Zhang Wu, Power Derek G, Bohanes Pierre, Gerger Armin, Wilson Peter M, Lurje Georg, Tang Laura H, Shah Manish, Lenz Heinz-Josef
Abstract excerpt
The cluster of differentiation 44 (CD44) signaling pathway is crucial in cancer-cell growth, invasion, proliferation and metastasis. CD44 is a transmembrane receptor for hyaluronan and osteopontin, and has recently attracted attention as a gastric cancer stem cell marker. Previous studies showed that polymorphisms in the CD44 gene can influence both human cancer survival and determine cellular response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
